MicroRNAs in the Atherosclerotic Plaque
2013/06/01 by Emma Raitoharju, Niku Oksala, Terho Lehtimäki · 27 citations
Biochemistry, Genetics and Molecular Biology · Neuroscience · Immunology and Microbiology · #MicroRNA in disease regulation #Nuclear Receptors and Signaling #Atherosclerosis and Cardiovascular Diseases
paper · pdf · doi:10.1373/clinchem.2013.204917
Abstract
BACKGROUND: MicroRNAs (miRNA, miR) are noncoding RNAs that regulate gene expression by hindering translation. miRNA expression profiles have been shown to differ in vivo and in vitro in many cellular processes associated with cardiovascular diseases (CVDs). The progression of CVDs has also been shown to alter the blood miRNA profile in humans. CONTENT: We summarize the results of animal and cell experiments concerning the miRNA profile in the atherosclerotic process and the changes which occur in the blood miRNA profile of individuals with CVD. We also survey the relationship of these CVD-related miRNAs and their expression in the human advanced atherosclerotic plaque, thereby providing more insight into miRNA function in human atherosclerotic lesions. The miRNAs miR-126, -134, -145, -146a, -198, -210, -340*, and -92a were found to be expressed differently in the blood of individuals affected and unaffected by CVD. These differences paralleled those seen in tissue comparisons of miRNA expression in advanced atherosclerotic plaques and healthy arteries. Furthermore, several miRNAs associated with atherosclerosis in in vitro studies (such as miR-10a, -126, -145, -146a/b, -185, -210, and -326) were expressed in plaques in a similar pattern as was predicted by the in vitro experiments. The clinical implications of miRNAs in atherosclerosis as biomarkers and as possible drug targets are also reviewed. SUMMARY: miRNA profiles in in vitro and in vivo studies as well as in human peripheral blood are quite representative of the miRNA expression in human atherosclerotic plaques. miRNAs appear promising in terms of future clinical applications.
Cited by
- Left Internal Mammary Artery as an Endocrine Organ: Insights Into Graft Biology and Long-term Impact Following Coronary Artery Bypass Grafting
- The Role of Inflammation in Cardiovascular Disease
- The Role of microRNAs in Mitochondria: Small Players Acting Wide. [europepmc]
- Circulating and renal vein levels of microRNAs in patients with renal artery stenosis. [europepmc]
- Epigenetic modulation in the treatment of atherosclerotic disease. [europepmc]
- Plasma miR-122 and miR-3149 Potentially Novel Biomarkers for Acute Coronary Syndrome. [europepmc]
- Small-nucleic-acid-based therapeutic strategy targeting the transcription factors regulating the vascular inflammation, remodeling and fibrosis in atherosclerosis. [europepmc]
- MicroRNA-143/-145 in Cardiovascular Diseases. [europepmc]
- Modulation of microRNA Expression in Subjects with Metabolic Syndrome and Decrease of Cholesterol Efflux from Macrophages via microRNA-33-Mediated Attenuation of ATP-Binding Cassette Transporter A1 Expression by Statins. [europepmc]
- Upregulation of microRNA-206 induces apoptosis of vascular smooth muscle cells and decreases risk of atherosclerosis through modulating FOXP1. [europepmc]
- Association of miR-21, miR-126 and miR-605 gene polymorphisms with ischemic stroke risk. [europepmc]
- Different expression of Micro RNA-126, 133a and 145 in aorta and saphenous vein samples of patients undergoing coronary artery bypass graft surgery. [europepmc]
- MicroRNA-331 and microRNA-151-3p as biomarkers in patients with ST-segment elevation myocardial infarction. [europepmc]
- MicroRNA-328-3p Protects Vascular Endothelial Cells Against Oxidized Low-Density Lipoprotein Induced Injury via Targeting Forkhead Box Protein O4 (FOXO4) in Atherosclerosis. [europepmc]
- Circulating plasma microRNA-126, microRNA-145, and microRNA-155 and their association with atherosclerotic plaque characteristics. [europepmc]
- Low MicroRNA-126 Levels in Right Ventricular Endomyocardial Biopsies Coincide With Cardiac Allograft Vasculopathy in Heart Transplant Patients. [europepmc]
- Circulating microRNA as a Biomarker for Coronary Artery Disease. [europepmc]
- Mir-1, miR-122, miR-132, and miR-133 Are Related to Subclinical Aortic Atherosclerosis Associated with Metabolic Syndrome. [europepmc]
- Circ_0004104 knockdown alleviates oxidized low-density lipoprotein-induced dysfunction in vascular endothelial cells through targeting miR-328-3p/TRIM14 axis in atherosclerosis. [europepmc]
- Adulthood blood levels of hsa-miR-29b-3p associate with preterm birth and adult metabolic and cognitive health. [europepmc]
- LncRNA EGOT/miR-211-5p Affected Radiosensitivity of Rectal Cancer by Competitively Regulating ErbB4. [europepmc]
- Exosomal Transfer of miR-185 Is Controlled by hnRNPA2B1 and Impairs Re-endothelialization After Vascular Injury. [europepmc]
- Profiling of Primary and Mature miRNA Expression in Atherosclerosis-Associated Cell Types. [europepmc]
- Human Prostate Tissue MicroRNAs and Their Predicted Target Pathways Linked to Prostate Cancer Risk Factors. [europepmc]
- Delivery of miR-654-5p via SonoVue Microbubble Ultrasound Inhibits Proliferation, Migration, and Invasion of Vascular Smooth Muscle Cells and Arterial Thrombosis and Stenosis through Targeting TCF21. [europepmc]
- The Role of Inflammation in Cardiovascular Disease. [europepmc]
- MicroRNAs Regulate Function in Atherosclerosis and Clinical Implications. [europepmc]
Related